Scientific Program - Saturday, November 21, 2015

Print

Session type:
Person:
Clear filters

Morning

07:00 a.m. - 08:00 a.m.
Industry Sponsored Breakfast
Location: Mouton


08:00 a.m. - 08:40 a.m.
Pornography and Non-Normative Sexual Behavior: Where to draw the line?
Location: Margaux 2
Moderators: Michael A. Perelman, PhD & Jess Waldura, MD, MAS

08:00 a.m. - 08:20 a.m.
Who are you Calling Deviant: Prevalence of Non-Normative Sexual Interests
Jess Waldura, MD, MAS

08:20 a.m. - 08:40 a.m.
Internet Pornography: Harmful to Men and Relationships?
Nicole Prause, PhD


08:00 a.m. - 09:00 a.m.
Video Session for Peyronie’s Surgery
Location: Latour Ballroom 2
Moderators: Brian S. Christine, MD & Ashley H. Tapscott, DO

08:00 a.m. - 08:20 a.m.
How I do Penile Plication
Laurence A. Levine, MD

08:20 a.m. - 08:40 a.m.
How I do Patch Grafting
Wayne J.G. Hellstrom, MD

08:40 a.m. - 09:00 a.m.
How I Manage Residual Curvature after IPP in PD
Brian S. Christine, MD


08:00 a.m. - 09:00 a.m.
Molecular Pathways in ED: Where are we going?
Location: Margaux 1
Moderators: Nestor Gonzalez-Cadavid, PhD & Nikolai Sopko, MD, PhD

08:00 a.m. - 08:30 a.m.
Sonic Hedgehog
Carol A. Podlasek, PhD

08:30 a.m. - 09:00 a.m.
Stem Cells/Cytokines
Trinity J. Bivalacqua, MD, PhD


08:40 a.m. - 09:00 a.m.
Future Drugs and Treatment of PE
Location: Margaux 2
Moderators: Michael A. Perelman, PhD & Jess Waldura, MD, MAS

08:40 a.m. - 09:00 a.m.
Future Drugs and Treatment of PE
Chris McMahon, MD


09:00 a.m. - 10:00 a.m.
Moderated Posters: Erectile Dysfunction Surgical I
Location: Latour Ballroom 2
Moderators: LeRoy A. Jones Jr., MD & Edward Karpman, MD

09:00 a.m. - 09:04 a.m.
The Effect of Hypogonadism on Post-Prostatectomy Erectile Function in Men Treated with Penile Rehabilitation (#059)
D.J. Lee

09:04 a.m. - 09:08 a.m.
The Impact of Surgical Approach on Corporal Sizing for Inflatable Penile Prosthesis Insertion (#060)
M.J. Pagano

09:08 a.m. - 09:12 a.m.
The who, how and what of Real-World Penile Implants Patients in 2015: The propper (Prospective Registry of Outcomes with Penile Prosthesis for Erectile Restoration) Registry Baseline Data (#061)
G. Henry

09:12 a.m. - 09:16 a.m.
"Just the Tip" Closed Suction Drain Cultures after Implantation of Penile Prosthesis (#062)
J. Wallen

09:16 a.m. - 09:20 a.m.
Influential Factors for Penile Implant Patient Satisfaction at 1 year from the PROPPER Registry (#063)
Tobias S. Köhler, MD, MPH

09:20 a.m. - 09:24 a.m.
Risk Factors for Surgical Revision after Penile Prosthesis Surgery (#064)
M. Pineda

09:24 a.m. - 09:28 a.m.
Erectile Function and Urinary Bother Following Radical Prostatectomy (RP) (#065)
Christian Nelson, PhD

09:28 a.m. - 09:32 a.m.
Prospective Evaluation of Postoperative Penile Rehabilitation: Penile Morphology and Patient Satisfaction 2 Years Following Coloplast Titan Inflatable Penile Prosthesis (#066)
G. Henry

09:32 a.m. - 09:36 a.m.
Multi-Institutional and Lasting Results with the MoST (Modified Sliding Technique) for Penile Lengthening with Penile Prosthesis Insertion (#067)
A. Weinberg

09:36 a.m. - 09:40 a.m.
Subcoronal IPP can be Performed under Local Anesthesia (#068)
S.S.H. Park

09:40 a.m. - 09:44 a.m.
Penile Intracavernosal Pillars: Lessons from Anatomy and Potential Implications for Penile Prosthesis Placement (#069)
M.J. Pagano

09:44 a.m. - 09:48 a.m.
Placement of Penile Prosthesis May Improve Metabolic Syndrome: Retrospective Cohort in a Single Site Institutional Experience (#070)
L. Ramos


09:00 a.m. - 10:00 a.m.
Moderated Posters: Basic Science II
Location: Margaux 1
Moderators: Michael E. DiSanto, PhD & Alexander W. Pastuszak, MD, PhD

09:00 a.m. - 09:07 a.m.
PKA Agonist Colforsin Recovers Erectile Function and Promotes nNOS Signalling in the Penis in Cavernous Nerve Injury Rat Model (#072)
Arthur L. Burnett II, MD

09:07 a.m. - 09:14 a.m.
Neurotoxic M1 Macrophages are Recruited to the Major Pelvic Ganglion by Increased TNF-alpha Following Bilateral Cavernous Nerve Injury (#073)
H. Matsui

09:14 a.m. - 09:21 a.m.
S-Nitrosoglutathione Reductase (GSNOR) Protects against Western Diet Induced Reactive Oxygen Species Production and Erectile Dysfunction (#074)
J.D. La Favor

09:21 a.m. - 09:28 a.m.
Protective Effect of Herbal Formulation in the Bladder of Androgen-Deprived Rat (#075)
K.S. Kim

09:28 a.m. - 09:35 a.m.
Correlation between Androgen Receptor CAG Repeat Length Polymorphism and Metabolic Syndrome, Late Onset Hypogonadism in Korean Male (#076)
D.G. Moon

09:35 a.m. - 09:42 a.m.
Protective Effect of KH-204 via ERK and Akt Pathways in LOH Rat Model (#077)
K.S. Kim

09:42 a.m. - 09:49 a.m.
Further Evidence for a Role of Human Growth Hormone (hGH) in the Control of Penile Erection in the Adult Male (#078)
S. Ückert

09:49 a.m. - 09:56 a.m.
Separate or Combined Treatments with Human Bone Marrow-Derived Stem Cells and Substance P of Erectile Dysfunction in a Rat Model of Diabetes (#079)
G.H. Song


09:00 a.m. - 10:00 a.m.
Moderated Posters: Female Sexual Dysfunction / Mental Health
Location: Margaux 2
Moderators: Christian Nelson, PhD & Daniela Wittmann, PhD, LMSW

09:00 a.m. - 09:05 a.m.
Successful Management of Clitorodynia Closed Compartment Syndrome (#080)
S.A. King

09:05 a.m. - 09:10 a.m.
Sub-Urethral Sling Surgery For Stress Incontinence May Result In Orgasmic Dysfunction Through Direct Injury to Anterior Vaginal Wall, Peri-Urethral Prostatic Tissue (#081)
Irwin Goldstein, MD

09:10 a.m. - 09:15 a.m.
Responder Analyses Based on Minimum Clinically Important Differences Derived from Receiver Operating Characteristic Curves in Premenopausal Women Using Bremelanotide for Female Sexual Dysfunctions (#082)
Stanley Althof, PhD

09:15 a.m. - 09:20 a.m.
Partner Prosthesis Panic (#083)
S.A. King

09:20 a.m. - 09:25 a.m.
Have Related Between Female Sexual Function and Male Partners’ Erectile Function? (#084)
K. Drasa

09:25 a.m. - 09:30 a.m.
‘A Rose By Any Other Name’: Historical Insights into Restless Genital Syndrome (RGS) (#085)
B. Chubak

09:30 a.m. - 09:35 a.m.
The Impact of Testicular Loss on the Psychopathology of Young Patient in Korea: Population-based Analysis of 4 Million Examinees of Manpower Administration Database for 10 Years (#086)
S.W. Lee

09:35 a.m. - 09:40 a.m.
Sexual Behavior Seems to Influence Depression (#087)
F. Ramirez

09:40 a.m. - 09:45 a.m.
Sexual Abuse Increases Risk of Addictive Behaviors (#088)
F. Ramirez

09:45 a.m. - 09:50 a.m.
Emotional Intelligence in Persons Involved in Sexual Relationships Outside Marriage (#089)
F. Ramirez

09:50 a.m. - 09:55 a.m.
Vaginal Dilation: Current Use and Treatment Practices Vaginal Dilator Clinician Survey: Preliminary Report Health Care Provider Insight (#090)
Michael Krychman, MD

09:55 a.m. - 10:00 a.m.
Barriers to Sexual Activity after Treatment for Head and Neck Cancer: A Qualitative Approach (#091)
B. Rhoten


10:00 a.m. - 10:30 a.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


10:30 a.m. - 11:00 a.m.
2nd Annual Robert Krane Lecture: Neuroplasticity: Implications for ED
Location: Margaux 1
Moderator: Carol A. Podlasek, PhD

10:30 a.m. - 11:00 a.m.
2nd Annual Robert Krane Lecture: Neuroplasticity: Implications for ED
Trinity J. Bivalacqua, MD, PhD


10:30 a.m. - 11:00 a.m.
Contraception and Sexual Health
Location: Margaux 2
Moderators: Sue W. Goldstein, BA & Christian Nelson, PhD

10:30 a.m. - 10:45 a.m.
How Contraceptive Options Affect Women’s Sexual Enjoyment
Tami Rowen, MD, MS

10:45 a.m. - 11:00 a.m.
Condoms and Male Sexual Function
Brian Dodge, PhD


10:30 a.m. - 12:00 p.m.
Tips from the Masters: How I Perform Penile Implant Surgery
Location: Latour Ballroom 2
Moderators: Mark E. Leo, MD & John J. Mulcahy, MD, PhD

10:30 a.m. - 10:48 a.m.
How to do Infrapubic IPP
Edward Karpman, MD

10:48 a.m. - 11:06 a.m.
How I do Antibiotics, Retractor Placement, and Corporal Exposure
Rafael E. Carrion, MD

11:06 a.m. - 11:24 a.m.
How I Measure, Dilate, and Place Corporal Cylinders
Brian S. Christine, MD

11:24 a.m. - 11:42 a.m.
How I Place the Reservoir and Dress the Wound
Steven K. Wilson, MD

11:42 a.m. - 12:00 p.m.
How I Prevent Infection
William O. Brant, MD


11:00 a.m. - 12:00 p.m.
Moderated Posters: Erectile Dysfunction Medical
Location: Margaux 1
Moderators: Nelson Bennett Jr., MD & Ira D. Sharlip, MD

11:00 a.m. - 11:05 a.m.
A Comparison of Baseline Erectile Function after On-Demand 20 mg Tadalafil vs. Daily 5 mg Tadalafil in Men with Erectile Dysfunction and Diabetes: A Prospective, Observational 2-year Study (#092)
N.C. Park

11:05 a.m. - 11:10 a.m.
Prevalence of Sex Stimulants Abuse among Male Subjects in Calabar, Cross River State, Nigeria, Following Perceived Beneficial Effect in Increasing Genital Size (#093)
V.U. Nna

11:10 a.m. - 11:15 a.m.
Relationship Between Age and Erectile Dysfunction Diagnosis or Treatment Using Real-World Observational Data in the United States (#094)
John Mulhall, MD

11:15 a.m. - 11:20 a.m.
Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction (#095)
Irwin Goldstein, MD

11:20 a.m. - 11:25 a.m.
Penile Rehabilitation Adherence and Outcomes: The First 6 Months of Treatment (#096)
Jeffrey Albaugh, PhD, APRN, CUCNS

11:25 a.m. - 11:30 a.m.
Preservation of Nocturnal Penile Tumescense with Daily Low-Dose Sildenafil 6 Weeks after Nerve-Sparing Radical Prostatectomy is Correlated with Erectile Function Rehabilitation (#097)
A. Bannowsky

11:30 a.m. - 11:35 a.m.
Prevalence and Predictors of Erectile Dysfunction in Men Evaluated for Infertility (#098)
C.D. Gaffney

11:35 a.m. - 11:40 a.m.
The Prevalence And Predictors Of Vasovagal Reactions In Men Being Trained In Penile Injection Therapy (#099)
John Mulhall, MD

11:40 a.m. - 11:45 a.m.
End Diastolic Velocity versus Resistive Indices in Predicting Better Clinical Response Using Penile Doppler Ultrasound for Patients with Erectile Dysfunction (#100)
C. McCraw

11:45 a.m. - 11:50 a.m.
Determining Factors Associated with Early Onset of Erectile Dysfunction (ED) in Men with Type 1 Diabetes (#101)
M.R. Palmer

11:50 a.m. - 11:55 a.m.
Sex & Intimacy after Prostate Cancer Treatment: What Men and Partners Say (#102)
Jeffrey Albaugh, PhD, APRN, CUCNS

11:55 a.m. - 12:00 p.m.
Does the Gender of the Primary Care Physician Influence whether they Inquire about Erectile Dysfunction? (#103)
M. Bickell


11:00 a.m. - 12:00 p.m.
Moderated Posters: BPH/Ejaculation/Orgasm
Location: Margaux 2
Moderators: Seth Cohen, MD, MPH & Michael A. Perelman, PhD

11:00 a.m. - 11:05 a.m.
Orgasm in Men on Androgen Deprivation Therapy (ADT) for Prostate Cancer (#104)
John Mulhall, MD

11:05 a.m. - 11:10 a.m.
Daily Modafinil Treatment may be Beneficial for the Treatment of Lifelong Premature Ejaculation (#105)
E.C. Serefoglu

11:10 a.m. - 11:15 a.m.
The Significance of Testosterone Levels and the Efficacy of Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms (#106)
N.C. Park

11:15 a.m. - 11:20 a.m.
Impact of Endogenous Hormonal Status on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5mg for LUTS/BPH (#108)
C. Donatucci

11:20 a.m. - 11:25 a.m.
Prostatic Urethral Lift: BPH Treatment for the Sexually Inclined (#109)
J. Beilan

11:25 a.m. - 11:30 a.m.
The Effect of Hyaluronic Acid/Carboxymethylcellulose Instillation to Prevent Urethral Stricture after Transurethral Bladder Surgery (#110)
S.U. Jeh

11:30 a.m. - 11:35 a.m.
Relationship between Serum Testosterone and Nocturia in Men with Normal Prostate Size (#111)
J.S. Hyun

11:35 a.m. - 11:40 a.m.
Post-Finasteride Syndrome - Outcomes of FDA Database (#112)
M. Butcher


Afternoon

12:00 p.m. - 01:30 p.m.
Industry Sponsored Lunch
Location: Mouton


01:30 p.m. - 02:30 p.m.
Moderated Posters: Peyronie’s Disease
Location: Margaux 1
Moderators: Boback Berookhim, MD, MBA & Yacov Reisman, MD, PhD

01:30 p.m. - 01:34 p.m.
The Effect of Duration of Daily Penile Traction in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease (#113)
F.A. Yafi

01:34 p.m. - 01:38 p.m.
Penile Prosthesis Can Safely and Easily Be Inserted in Patients with Peyronie's Disease: Results of the PROPPER Study (#114)
Mohit Khera, MD

01:38 p.m. - 01:42 p.m.
Preliminary Data In A Longitudinal Analysis of the Psychological and Relationship Impact of Peyronie’s Disease (PD) (#115)
Lawrence C. Jenkins, MD, MBA

01:42 p.m. - 01:46 p.m.
Positive Results with Collagenase Clostridium histolyticum Treatment in Two Patients with Ventral Penile Curvature Due to Peyronie’s Disease (#116)
D. Milam

01:46 p.m. - 01:50 p.m.
Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie’s Disease (#117)
M.J. Ziegelmann

01:50 p.m. - 01:54 p.m.
Penile Prosthesis Ventral Extrusion: An Unforeseen Consequence of Penile Modeling in Peyronie’s Disease (#118)
S.C. Pate

01:54 p.m. - 01:58 p.m.
Peyronie's Disease Symptom Prevalence, Bother and Risk Factors in Dupuytren's Disease Patients (#119)
G.H. Sweet

01:58 p.m. - 02:02 p.m.
Erectile and Non-erectile Sexual Dysfunction in Men with Peyronie's Disease (#120)
I.C. Onyeji

02:02 p.m. - 02:06 p.m.
Characterizing Peyronie’s Disease And Its Response To Intralesional Verapamil In Men Developing Peyronie’s Disease After Radical Prostatectomy (#121)
Kelly Chiles, MD

02:06 p.m. - 02:10 p.m.
Assessing the Impact of Change in Penile Rigidity on Degree of Penile Curvature in Men with Peyronie’s Disease (PD) (#122)
Lawrence C. Jenkins, MD, MBA

02:10 p.m. - 02:14 p.m.
A Preliminary Report on Xiaflex Therapy Outcomes for Peyronie's Disease After a Year of Implementation at a Single REMS Institution (#123)
J. Fisher

02:14 p.m. - 02:18 p.m.
Dissecting the Peyronie’s Disease Questionnaire (PDQ): What Matters Most in the Initial Evaluation of Patients with Peyronie’s Disease ? (#124)
S. Honig

02:18 p.m. - 02:22 p.m.
Initial Peyronie’s Disease Questionnaire Bother Scores do not Correlate with Degree of Penile Curvature in Patients with Peyronie’s Disease (#125)
S. Honig

02:22 p.m. - 02:26 p.m.
Effects of Combination Therapy of Tamoxifen, L-carnitine and Daily PDE5 Inhibitors in the Peyronie's Disease (#126)
D.G. Moon


01:30 p.m. - 02:30 p.m.
Moderated Posters: Androgens II
Location: Margaux 2
Moderators: Serge Carrier, MD & Kenneth Mitchell, MPAS, PA-C

01:30 p.m. - 01:35 p.m.
High Dose Testosterone and Other Performance Enhancing Drug Use in Professional Male Bodybuilders Is Associated with Increased Mortality (#127)
A. Allison

01:35 p.m. - 01:40 p.m.
Testosterone Enanthate Administered Once-Weekly by Subcutaneous Auto Injector in Men with Hypogonadism: Pharmacokinetic and Safety Results from a Phase III Trial (#128)
J.C. Kaminetsky

01:40 p.m. - 01:45 p.m.
Comparison of the Effects of Oral Enclomiphene Citrate and Topical Testosterone Gels Treatment on Serum Hormones, Erythrocytosis, Lipids, and Prostate Specific Antigen (#129)
Alexander W. Pastuszak, MD, PhD

01:45 p.m. - 01:50 p.m.
Testosterone Inhibits the Growth of Prostate Cancer Xenografts in Nude Mice (#130)
Mohit Khera, MD

01:50 p.m. - 01:55 p.m.
Age and Body Mass Index are Independent Predictors of Testosterone Deficiency in Men with Erectile Dysfunction (#131)
M.J. Pagano

01:55 p.m. - 02:00 p.m.
The Ubiquitous Availability and Easy Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet (#132)
J.A. McBride

02:00 p.m. - 02:05 p.m.
Female Post-Finasteride Syndrome : It’s Not Just A Man’s World (#133)
J. Fiuk

02:05 p.m. - 02:10 p.m.
A Critical Evaluation of the Readability, Credibility, and Quality of High Ranking Websites Proclaiming to Provide Patient Centered Information on Hypogonadism (#134)
J.A. McBride

02:10 p.m. - 02:15 p.m.
Low Plasma Testosterone is Associated with Elevated Cardiovascular Disease Biomarkers (#135)
Alexander W. Pastuszak, MD, PhD

02:15 p.m. - 02:20 p.m.
Testosterone Replacement Therapy in Adolescents with Sickle Cell Disease Reverses Hypogonadism without Promoting Priapism (#136)
B. Morrison

02:20 p.m. - 02:25 p.m.
Low Dose Growth Hormone Releasing Peptide Treatment Does Not Increase Serum IGF-1 Levels in Men (#137)
M.C. Lindgren

02:25 p.m. - 02:30 p.m.
Effect of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men (#138)
D. Heiselman


01:30 p.m. - 03:30 p.m.
Sexual Health and Trauma: Recovering & Restoring Pleasure
Location: Latour Ballroom 2
Moderators: Gregory A. Broderick, MD, Hossein Sadeghi-Nejad, MD, FACS & Ira D. Sharlip, MD

01:30 p.m. - 01:50 p.m.
Sexual rehabilitation: Adaptive Strategies for Physical Limitations and Pain
Heather S. Howard, PhD, MPH

01:50 p.m. - 02:10 p.m.
Sexual Wellness in Veterans of Recent Wars
Benjamin N. Breyer, MD

02:10 p.m. - 02:30 p.m.
Fertility in Veterans of Recent Wars
Robert C. Dean, MD

02:30 p.m. - 02:45 p.m.
Presentation by wounded veteran

02:45 p.m. - 03:05 p.m.
Uropac and Urotrauma Bill
Robert C. Dean, MD

03:05 p.m. - 03:20 p.m.
SMSNA Legislative Affairs Committee

03:20 a.m. - 03:30 a.m.
Q&A


02:30 p.m. - 03:30 p.m.
Broadening the Patient Base
Location: Margaux 1
Moderators: David Latini, PhD & Tami Rowen, MD, MS

02:30 p.m. - 02:50 p.m.
Sexual Wellness in Transgender Persons
Maurice Garcia, MD, MAS

02:50 p.m. - 03:10 p.m.
BDSM and Alternative Relationships: A primer
Jess Waldura, MD, MAS

03:10 p.m. - 03:30 p.m.
Sexual Wellness in Gay Men: Beyond HIV Prevention
Billy H. Cordon, MD


02:30 p.m. - 03:30 p.m.
Moderated Posters: Erectile Dysfunction Surgical II
Location: Margaux 2
Moderators: William P. Conners, MD & Ronald W. Lewis, MD

02:30 p.m. - 02:34 p.m.
Subcutaneous Placement of Inflatable Penile Prosthesis Reservoirs (#149)
M. Bickell

02:34 p.m. - 02:38 p.m.
Complications of “Drained and Retained” Urologic Prosthetic Components (#139)
S.C. Pate

02:38 p.m. - 02:42 p.m.
Penile Prosthesis Implantation in Patients with Severe Corporal Fibrosis After Mechanical Therapy (#140)
P. Tsambarlis

02:42 p.m. - 02:46 p.m.
Use of Dorsal Nerve Block with Bupivacaine Liposome Injectable Suspension (Exparel) for Pain Management Following Three-Piece Penile Prosthesis Surgery (#141)
S.A. King

02:46 p.m. - 02:50 p.m.
Preoperative Local Anesthetic Block Reduces the Need for Narcotic Medications Following Penile Prosthesis Surgery (#142)
A. Weinberg

02:50 p.m. - 02:54 p.m.
Medium-term Outcomes of the MINT Technique for IPP Surgery in 180 Consecutive Patients (#143)
C. Love

02:54 p.m. - 02:58 p.m.
Preop vs. Postop Penile Length/Girth Maintenance and Satisfaction Following AMS 700 LGX Inflatable Penile Prosthesis Implantation (#144)
M. Gross

02:58 p.m. - 03:02 p.m.
A Contemporary Series of Penile Implant Complications Occurring at a Training Institution (#145)
J. Ring

03:02 p.m. - 03:06 p.m.
HIV-Positive Status does not Increase Risk of Penile Prosthesis Infection (#146)
N. Davoudzadeh

03:06 p.m. - 03:10 p.m.
Treatment Satisfaction after Penile Prosthesis Surgery is Higher for Virgin Cases Compared to Revision Cases (#147)
M. Pineda

03:10 p.m. - 03:14 p.m.
“The Wang Collar:” A Novel Post Operative Device after Inflatable Penile Prosthesis Placement (#148)
C. Benson

03:14 p.m. - 03:18 p.m.
A Streamline Approach to Inflatable Penile Prosthesis Placement (#150)
A. Weinberg

03:18 p.m. - 03:22 p.m.
Synchronous Dual AUS/IPP Insertion through a Single Penoscrotal Incision (#151)
F.A. Yafi

03:26 p.m. - 03:30 p.m.
Post-Prostatectomy Penile Prosthesis Reservoir Placement with Radiographic Guidance (#071)
D.G. Song


03:30 p.m. - 04:00 p.m.
Coffee Break
Location: Latour Ballroom 3, 5, 6 & 7


04:00 p.m. - 05:00 p.m.
ISSM Symposium
Location: Latour Ballroom 2
Moderator: Wayne J.G. Hellstrom, MD

04:00 p.m. - 04:15 p.m.
Perspectives in Testosterone Replacement Therapy (TRT)
Wayne J.G. Hellstrom, MD

04:15 p.m. - 04:30 p.m.
Xiaflex as a treatment for Peyronie`s Disease
Chris McMahon, MD

04:30 p.m. - 04:45 p.m.
ED as a Marker of Cardiovascular Disease
Luiz Otavio Torres, MD

04:45 p.m. - 05:00 p.m.
Is there really anything new in Male Sexual Health since the discovery of PDE5i's?
Gerald B. Brock, MD


05:00 p.m. - 05:30 p.m.
SMSNA Business Meeting (members only)
Location: Latour Ballroom 2


05:30 p.m. - 05:45 p.m.
SUPS Business Meeting (members only)
Location: Latour Ballroom 2


Evening

06:00 p.m. - 07:00 p.m.
Young Clinicians Mixer
Location: Montrachet Patio